DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
LBS-008
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LBS-008
×
Maximum Phase:
1
First Approval:
None
UNII:
63WI9S8P1M
Molecule Type:
Small molecule
Molecular Formula:
C21H21F5N4O2
Molecular Weight:
456.42
AlogP:
3.63
PSA:
69.3
HBD:
1.0
HBA:
#RotB:
2.0
Source:
CORDYCEPIN
1
Small molecule
Investigational
Unknown
Unknown
Leukemia
Unknown
CORDYCEPIN
×
Maximum Phase:
1
First Approval:
None
UNII:
GZ8VF4M2J8
Molecule Type:
Small molecule
Molecular Formula:
C10H13N5O3
Molecular Weight:
251.25
AlogP:
-0.95
PSA:
119.31
HBD:
3.0
HBA:
#RotB:
2.0
Source:
BAY-1125976
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Serine/threonine-protein kinase AKT2 inhibitor
BAY-1125976
×
Maximum Phase:
1
First Approval:
None
UNII:
ZL7A1UM87X
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TRICETAMIDE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Tyrosine-protein kinase JAK1 inhibitor
TRICETAMIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
V6X0RFU7AF
Molecule Type:
Small molecule
Molecular Formula:
C16H24N2O5
Molecular Weight:
324.38
AlogP:
1.31
PSA:
77.1
HBD:
1.0
HBA:
#RotB:
8.0
Source:
MK-6186
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
MK-6186
×
Maximum Phase:
1
First Approval:
None
UNII:
K3978U665M
Molecule Type:
Small molecule
Molecular Formula:
C21H12Cl2N6O
Molecular Weight:
435.27
AlogP:
5.33
PSA:
92.41
HBD:
1.0
HBA:
#RotB:
4.0
Source:
TRICHOSTATIN A
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
TRICHOSTATIN A
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MURIZATOCLAX
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Multiple Myeloma; Myelodysplastic Syndromes
Unknown
MURIZATOCLAX
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C42H57ClN4O5S
Molecular Weight:
765.46
AlogP:
6.44
PSA:
91.42
HBD:
1.0
HBA:
#RotB:
3.0
Source:
MK-8325
1
Unknown
Investigational
Unknown
Unknown
Hepatitis C, Chronic
Unknown
MK-8325
×
Maximum Phase:
1
First Approval:
None
UNII:
779TT17O5A
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
THIAMPHENICOL
1
Small molecule
Investigational
Unknown
Unknown
Bacterial Infections
Unknown
THIAMPHENICOL
×
Maximum Phase:
1
First Approval:
None
UNII:
FLQ7571NPM
Molecule Type:
Small molecule
Molecular Formula:
C12H15Cl2NO5S
Molecular Weight:
356.23
AlogP:
0.4
PSA:
103.7
HBD:
3.0
HBA:
#RotB:
6.0
Source:
BTI-410
1
Unknown
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
BTI-410
×
Maximum Phase:
1
First Approval:
None
UNII:
D5DS571AIS
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FOLIGLURAX
1
Small molecule
Investigational
Unknown
Unknown
Parkinson Disease
Metabotropic glutamate receptor 4 positive allosteric modulator
FOLIGLURAX
×
Maximum Phase:
1
First Approval:
None
UNII:
FR50CP1D6W
Molecule Type:
Small molecule
Molecular Formula:
C23H23N3O3S
Molecular Weight:
421.52
AlogP:
4.26
PSA:
71.09
HBD:
1.0
HBA:
#RotB:
5.0
Source:
CINOBUFOTALIN
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CINOBUFOTALIN
×
Maximum Phase:
1
First Approval:
None
UNII:
L0QBZ37386
Molecule Type:
Small molecule
Molecular Formula:
C26H34O7
Molecular Weight:
458.55
AlogP:
2.91
PSA:
109.5
HBD:
2.0
HBA:
#RotB:
2.0
Source:
RUNIMOTAMAB
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
RUNIMOTAMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SIRPIGLENASTAT
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SIRPIGLENASTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C22H27N5O5
Molecular Weight:
441.49
AlogP:
1.3
PSA:
153.76
HBD:
3.0
HBA:
#RotB:
11.0
Source:
MP-0250
1
Unknown
Investigational
Unknown
Unknown
Multiple Myeloma; Neoplasms
Unknown
MP-0250
×
Maximum Phase:
1
First Approval:
None
UNII:
UGI01OSA4N
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AV0113 DC-CIT
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
AV0113 DC-CIT
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BFCR4350A
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
BFCR4350A
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CYC065
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
CYC065
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LITOXETINE
1
Small molecule
Investigational
Unknown
Unknown
Urinary Incontinence
Unknown
LITOXETINE
×
Maximum Phase:
1
First Approval:
None
UNII:
9980ST005G
Molecule Type:
Small molecule
Molecular Formula:
C16H19NO
Molecular Weight:
241.33
AlogP:
3.11
PSA:
21.26
HBD:
1.0
HBA:
#RotB:
3.0
Source:
F-18-ISO
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
F-18-ISO
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LY-3009120
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Melanoma; Neoplasm Metastasis
Serine/threonine-protein kinase A-Raf inhibitor
LY-3009120
×
Maximum Phase:
1
First Approval:
None
UNII:
1GDT36RARO
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TB-403
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Placenta growth factor inhibitor
TB-403
×
Maximum Phase:
1
First Approval:
None
UNII:
46MVG4H2LF
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-04991532
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Hexokinase type IV activator
PF-04991532
×
Maximum Phase:
1
First Approval:
None
UNII:
AJ212MS2O2
Molecule Type:
Small molecule
Molecular Formula:
C18H19F3N4O3
Molecular Weight:
396.37
AlogP:
3.76
PSA:
97.11
HBD:
2.0
HBA:
#RotB:
6.0
Source:
DOTAMTATE PB-212
1
Unknown
Investigational
Unknown
Unknown
Neuroendocrine Tumors
Unknown
DOTAMTATE PB-212
×
Maximum Phase:
1
First Approval:
None
UNII:
E9N7QV53AK
Molecule Type:
Unknown
Molecular Formula:
C65H91N17O16PbS2
Molecular Weight:
1642.67
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
OTX-008
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
OTX-008
×
Maximum Phase:
1
First Approval:
None
UNII:
8JI63CFH5V
Molecule Type:
Small molecule
Molecular Formula:
C52H72N8O8
Molecular Weight:
937.2
AlogP:
2.59
PSA:
166.28
HBD:
4.0
HBA:
#RotB:
24.0
Source:
YTTRIUM Y 90 EPRATUZUMAB
1
Antibody
Investigational
Unknown
Unknown
Unknown
CD22 binding agent
YTTRIUM Y 90 EPRATUZUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CETUXIMAB SAROTALOCAN
1
Antibody
Investigational
Unknown
Unknown
Unknown
Epidermal growth factor receptor erbB1 binding agent
CETUXIMAB SAROTALOCAN
×
Maximum Phase:
1
First Approval:
None
UNII:
MG94W1I5XW
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ATAMPARIB
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Unknown
ATAMPARIB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
KB-004
1
Antibody
Investigational
Unknown
Unknown
Glioblastoma; Myelodysplastic Syndromes; Primary Myelofibrosis
Ephrin type-A receptor 3 inhibitor
KB-004
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PUQUITINIB
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Epidermal growth factor receptor erbB1 inhibitor
PUQUITINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
WFG29AB872
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MK-2748
1
Small molecule
Investigational
Unknown
Unknown
Hepatitis C
Unknown
MK-2748
×
Maximum Phase:
1
First Approval:
None
UNII:
7YM030A71C
Molecule Type:
Small molecule
Molecular Formula:
C42H56N6O10S
Molecular Weight:
837.01
AlogP:
3.84
PSA:
204.33
HBD:
3.0
HBA:
#RotB:
8.0
Source:
LY-3076226
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
LY-3076226
×
Maximum Phase:
1
First Approval:
None
UNII:
GP2L3N7FIM
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LGX-806
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Serine/threonine-protein kinase B-raf inhibitor
LGX-806
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
2-DEOXY-D-GLUCOSE
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant
Unknown
2-DEOXY-D-GLUCOSE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C6H12O5
Molecular Weight:
164.16
AlogP:
-2.19
PSA:
90.15
HBD:
4.0
HBA:
#RotB:
1.0
Source:
PRI-724
1
Unknown
Investigational
Unknown
Unknown
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Neoplasms; Colorectal Neoplasms
CBP/beta catenin inhibitor
PRI-724
×
Maximum Phase:
1
First Approval:
None
UNII:
43Y934BBZ6
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
105
106
107
108
109
110
111
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA